BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36971307)

  • 1. Mycosis fungoides and Sézary syndrome - Review and outlook.
    Latzka J; Trautinger F
    J Dtsch Dermatol Ges; 2023 Apr; 21(4):386-391. PubMed ID: 36971307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2023.
    Latzka J; Assaf C; Bagot M; Cozzio A; Dummer R; Guenova E; Gniadecki R; Hodak E; Jonak C; Klemke CD; Knobler R; Morrris S; Nicolay JP; Ortiz-Romero PL; Papadavid E; Pimpinelli N; Quaglino P; Ranki A; Scarisbrick J; Stadler R; Väkevä L; Vermeer MH; Wehkamp U; Whittaker S; Willemze R; Trautinger F
    Eur J Cancer; 2023 Dec; 195():113343. PubMed ID: 37890355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A large single-center experience with allogeneic stem-cell transplantation for peripheral T-cell non-Hodgkin lymphoma and advanced mycosis fungoides/Sezary syndrome.
    Jacobsen ED; Kim HT; Ho VT; Cutler CS; Koreth J; Fisher DC; Armand P; Alyea EP; Freedman AS; Soiffer RJ; Antin JH
    Ann Oncol; 2011 Jul; 22(7):1608-1613. PubMed ID: 21252059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycosis fungoides and Sézary syndrome: clinical, histopathological and immunohistochemical review and update.
    Yamashita T; Abbade LP; Marques ME; Marques SA
    An Bras Dermatol; 2012; 87(6):817-28; quiz 829-30. PubMed ID: 23197199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycosis fungoides and Sézary syndrome: a population-wide study on prevalence and health care use in Finland in 1998-2016.
    Keto J; Hahtola S; Linna M; Väkevä L
    BMC Health Serv Res; 2021 Feb; 21(1):166. PubMed ID: 33618714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bridging the specialty gap: Update on primary cutaneous lymphomas.
    Olsen EA; Hodak E; Geskin L; Scarisbrick J;
    J Am Acad Dermatol; 2024 Feb; 90(2):257-260. PubMed ID: 38043039
    [No Abstract]   [Full Text] [Related]  

  • 7. The biomarker landscape in mycosis fungoides and Sézary syndrome.
    Dulmage B; Geskin L; Guitart J; Akilov OE
    Exp Dermatol; 2017 Aug; 26(8):668-676. PubMed ID: 27897325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes to Registered and Pivotal Clinical Trials after the 2011 Tri-Societies Guidelines for Clinical Endpoints and Response Criteria in Mycosis Fungoides and Sézary Syndrome.
    Gunter SJ; Kim EJ
    J Invest Dermatol; 2024 Apr; 144(4):855-861.e1. PubMed ID: 37925066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous T-cell Lymphomas: A Single-center Retrospective Analysis.
    Kaemmerer T; Guertler A; Clanner-Engelshofen BM; Fuchs C; French LE; Reinholz M
    Acta Dermatovenerol Croat; 2023 Dec; 31(4):184-190. PubMed ID: 38651844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study.
    de Masson A; Beylot-Barry M; Ram-Wolff C; Mear JB; Dalle S; d'Incan M; Ingen-Housz-Oro S; Orvain C; Abraham J; Dereure O; Charbonnier A; Cornillon J; Longvert C; Barete S; Boulinguez S; Wierzbicka-Hainaut E; Aubin F; Rubio MT; Bernard M; Schmidt-Tanguy A; Houot R; Pham-Ledard A; Michonneau D; Brice P; Labussière-Wallet H; Bouaziz JD; Grange F; Moins-Teisserenc H; Jondeau K; Michel L; Mourah S; Battistella M; Daguindau E; Loschi M; Picard A; Franck N; Maillard N; Huynh A; Nguyen S; Marçais A; Chaby G; Ceballos P; Le Corre Y; Maury S; Bay JO; Adamski H; Bachy E; Forcade E; Socié G; Bagot M; Chevret S; Peffault de Latour R; ; ;
    Lancet; 2023 Jun; 401(10392):1941-1950. PubMed ID: 37105210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Outcomes of COVID-19 in Mycosis Fungoides and Sezary Syndrome.
    Levy Yurkovski I; Rokach L; Melamed G; Alapi H; Gazit S; Patalon T; Tadmor T
    Acta Haematol; 2023; 146(6):496-503. PubMed ID: 37517402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial Disparities in Mycosis Fungoides/Sézary Syndrome-A Single-Center Observational Study of 292 Patients.
    Gandham AR; Geller S; Dusza SW; Kupper TS; Myskowski PL
    Clin Lymphoma Myeloma Leuk; 2024 Apr; 24(4):e174-e180. PubMed ID: 38245472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Itchy Skin: A Challenging Differential Diagnosis Between Mycosis Fungoides and Sézary Syndrome.
    Abreu Rocha C; Drummond Borges M; Santos GM; Sousa M; Teixeira T
    Cureus; 2023 Oct; 15(10):e46427. PubMed ID: 37927614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two cases of mycosis fungoides with large cell transformation with KMT2A rearrangements.
    Wadsworth PA; Lawrence L; Suarez CJ; Saleem A; Khodadoust MS; Kim YH; Rieger KE; Fernandez-Pol S
    J Hematop; 2023 Dec; 16(4):227-234. PubMed ID: 38175436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sezary Syndrome: A Case Report and Review of Current Therapeutics.
    Krishnan J; Thanikachalam K
    Cureus; 2024 Apr; 16(4):e58570. PubMed ID: 38765439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five paediatric patients with mycosis fungoides and our approach to provide age-appropriate information and psychological support.
    Melchionda V; Ieremia E; Matin R; McPherson T
    Clin Exp Dermatol; 2024 Apr; 49(5):497-501. PubMed ID: 38169346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The current management of mycosis fungoides and Sézary syndrome and the role of radiotherapy: Principles and indications.
    Mazzeo E; Rubino L; Buglione M; Antognoni P; Magrini SM; Bertoni F; Parmiggiani M; Barbieri P; Bertoni F
    Rep Pract Oncol Radiother; 2014 Mar; 19(2):77-91. PubMed ID: 24936325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics, initial treatment, and prognosis of mycosis fungoides and Sézary syndrome: A retrospective, single-center study at the Centre Hospitalier Universitaire of Quebec.
    Lachance M; Thibeault MM
    Ann Dermatol Venereol; 2023 Dec; 150(4):276-280. PubMed ID: 37777355
    [No Abstract]   [Full Text] [Related]  

  • 19. [Epidemiologie reifzelliger T- und NK-Zell-Lymphome in Deutschland - Eine repräsentative Querschnittanalyse von GKV-Routinedaten: Epidemiology of mature T/NK-cell lymphomas in Germany - A representative cross-sectional study based on SHI claims data].
    Assaf C; Dobos G; Zech IM; Doess A; May M; Jadasz J
    J Dtsch Dermatol Ges; 2023 Nov; 21(11):1320-1328. PubMed ID: 37946651
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.